The association between FGF-23 and hsCRP with composite CV death or hospitalization for heart failure (HHF), HHF, CV death, and major adverse CV events were assessed using multivariable Cox proportional hazard models adjusted for clinical risk factors, and markers of cardiac and renal injury. Here, FGF23 is linked to heart failure.